A Medigene platform · Omnichannel HCP engagement

One knowledge network for everyone in the care chain

A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.

Who MedShorts servesProgrammes for pharma

The MedShorts network

DoctorsClinical updates in five minutes or less
PharmacistsDispensing, counselling and safety capsules
Field forceProduct knowledge, certification and shareable links
One dashboardReach, engagement and learning, by audience
MedShorts 360 · Latest

Latest news, 14 November 2026

One new story for each specialty, every morning: short, sourced and readable between patients.

CardiologyCardiology

STREAM trial: stopping statins in over-70s without heart disease meets noninferiority, but events rose

In 1,880 multimorbid adults aged 70+ on statins for primary prevention, stopping was noninferior to continuing at two years, yet primary events were 12.7% vs 9.2% and quality of life, pain and falls did not improve.

Medical Dialogues
DiabetologyDiabetology

Early metformin in gestational diabetes linked to fewer insulin starts in EMERGE trial reanalysis

A reanalysis of the Irish EMERGE trial of 526 pregnancies with gestational diabetes found early metformin reduced the need for insulin (about 38% vs 51%), although the trial's original primary composite outcome had been neutral.

Diabetes.co.uk
NephrologyNephrology

Protein intake below 0.6 g/kg/day linked to higher kidney failure and death risk in CKD: KNOW-CKD

In 1,861 Korean adults with non-dialysis CKD followed for a median 9.3 years, protein intake under 0.6 g/kg/day was associated with 42% higher risk of kidney replacement therapy and about twice the mortality versus intake of 1.2 g/kg/day or more.

AJMC
NeurologyNeurology

Work exposure to petroleum-based lubricants linked to 38% higher odds of multiple sclerosis

A Swedish case-control study of 2,872 people with MS and 6,122 controls found occupational exposure to cutting fluids, engine oil and similar lubricants was associated with higher MS odds, with a dose-response pattern and interaction with smoking.

Healio
UrologyUrology

Indian review proposes urethral plate and glans width algorithm to choose distal hypospadias repair

A systematic review of 14 studies covering 1,348 children suggests measuring urethral plate width at the glanular B-point together with glans width to select the repair technique, as small glans width strongly predicted complications.

Medical Dialogues
PsychiatryPsychiatry

Newly diagnosed coeliac disease linked to 39% higher risk of eating disorders: Swedish cohort

In 37,853 Swedes with biopsy-confirmed coeliac disease, eating disorder risk was 39% higher than in matched controls, mostly in the first 5 years after diagnosis. Absolute risk stayed low, and first-degree relatives showed no clear rise in risk.

JAMA Network Open
PulmonologyPulmonology

TRIUMPH-OSA trials: weekly retatrutide cuts sleep apnoea severity in adults with obesity

In two 80-week NEJM phase 3 trials in moderate-to-severe OSA with obesity, weekly retatrutide 9 or 12 mg lowered the apnoea-hypopnoea index by about 22 to 24 events per hour more than placebo in people without diabetes, and by about 14 to 15 events per hour in those with diabetes.

Healio
Critical CareCritical Care

Cefazolin matches cloxacillin on 90-day mortality in MSSA bacteraemia with less kidney injury

A Bayesian meta-analysis of the SNAP and CloCeBa trials (1,579 patients) found cefazolin noninferior to cloxacillin or flucloxacillin for 90-day mortality in MSSA bacteraemia. Cefazolin led to fewer stoppages for adverse events and less acute kidney injury.

JAMA Network Open
GastroenterologyGastroenterology

Indian multicentre study: sarcopenia doubles death risk after gastric variceal bleeding in cirrhosis

In 318 patients with cirrhosis treated for bleeding gastric varices at six Indian centres, sarcopenia on CT or MRI was independently linked to more rebleeding, more hepatic decompensation and nearly double the risk of death.

Medical Dialogues
DermatologyDermatology

End-of-dose flares may guide whether to intensify biologics or add antibiotics in hidradenitis suppurativa

In a French retrospective cohort of 107 HS patients with frequent flares on standard-dose anti-TNF or anti-IL-17 biologics, choosing dose intensification or added antibiotics by end-of-dose effect was linked to mean IHS4 falling from 7.0 to 3.9.

Medical Dialogues
OphthalmologyOphthalmology

Duplicate OCT scans across public glaucoma datasets inflate reported accuracy of AI models

A JAMA Ophthalmology audit found that 79.2% of 1,302 linked eye pairs across three public glaucoma datasets were the same OCT volume under different IDs, inflating a classifier's cross-dataset AUC from 0.78 to 0.90.

JAMA Ophthalmology
ENTENT

New preoperative index helps predict which chronic rhinosinusitis patients improve after sinus surgery

In a 450-patient prospective cohort, a four-grade CRS Severity Index combining SNOT-22, symptom phenotype and CT and endoscopy scores separated meaningful improvement after endoscopic sinus surgery from 81% in the best grade to 29% in the worst.

JAMA Otolaryngology–Head & Neck Surgery
OrthopaedicsOrthopaedics

Indian case-control study finds no link between ABO blood group and adolescent idiopathic scoliosis

Comparing 133 surgically treated adolescent idiopathic scoliosis patients with 140 matched controls, researchers found no significant association between ABO blood group and scoliosis and advised against blood typing for risk assessment.

Medical Dialogues
GynaecologyGynaecology

First-trimester doxycycline linked to higher pregnancy loss than amoxicillin in US cohort study

In over 224,000 US pregnancies, first-trimester doxycycline for respiratory infection carried a 40-54% higher relative risk of pregnancy loss than amoxicillin; findings for acne were inconsistent.

2 Minute Medicine
PaediatricsPaediatrics

Biomarker-guided antibiotics for early-onset sepsis in very preterm infants fail noninferiority test

In an Italian 17-NICU trial of 283 very preterm infants, procalcitonin- and presepsin-guided antibiotics cut antibiotic starts from 98% to 58%, but noninferiority for survival without major morbidity was not shown.

JAMA Network Open
SurgerySurgery

Prone positioning after cardiac surgery doubles oxygenation in ARDS without raising sternal infection

In 38 adults with ARDS within a month of median sternotomy, prone sessions raised PaO2/FiO2 from about 83 to 175 mmHg, with one case of mediastinitis; in-hospital mortality remained high at 44.7%.

Medical Dialogues
General MedicineGeneral Medicine

Low-cost optical solubility test detects sickle haemoglobin with 98% accuracy in Indian evaluation

In 1,024 stored blood samples tested against HPLC, a portable absorbance-based sickle solubility kit showed 96.1% sensitivity and 99.8% specificity, supporting its potential use as a frontline screening tool.

Medical Dialogues
17 new today · 17 latest storiesSee all MedShorts 360 stories →
Get the MedShorts app

Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.

Why MedShorts is changing

Medical communication has outgrown the single doctor visit

Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.

MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.

The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.

What changes with MedShorts

01
From one audience to threeContent written separately for prescribers, dispensers and representatives, from the same evidence base.
02
From campaigns to a programmeA planned calendar of short updates across the year instead of one-off mailers.
03
From clicks to insightEngagement data by specialty, geography and audience, fed back into the next cycle.
04
From information to learningQuizzes, certification and links to Medigene CME where a deeper course exists.
Who MedShorts serves

Built for three roles that shape every treatment

Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.

For doctors

Clinical knowledge between consultations

Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.

  • Read or watch in under five minutes
  • Specialty-specific libraries
  • Patient education material to share
MedShorts for doctors →
For pharmacists

Confident counselling at the counter

Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.

  • Counselling scripts and checklists
  • Drug interaction and safety alerts
  • Available in English and Hindi
MedShorts for pharmacists →
For field force

Scientific confidence in every call

Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.

  • Daily five-minute learning bursts
  • Quizzes and product certification
  • Compliant, trackable sharing
MedShorts for field force →
The connected care chain

One message, from the representative to the patient

When all three roles learn from the same source, the patient hears one consistent story about their treatment.

Field representative

Learns the evidence, passes certification, shares an approved MedShorts link.

Doctor

Reviews the update in minutes, prescribes with the latest guidance, shares patient material.

Pharmacist

Dispenses correctly and counsels on dose, timing, side-effects and adherence.

MedShorts hubShared evidence base, medical review, multi-language content and one analytics layer across all three audiences.See the programme model
Strategic pillars

Five things MedShorts is built on

Short, evidence-led content

Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.

Reach where people already are

Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.

Learning, not just reading

Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.

Insight for brand teams

Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.

Trust and compliance

Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.

India-first delivery

Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.

How it works

Receive, open, learn, act

Receive

A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.

Open

One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.

Learn

Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.

Act

Apply it in practice, share patient material, or continue to a full CME course.

Measure

Engagement flows into the brand dashboard and shapes the next content cycle.

Content formats

The right format for every minute available

Clinical shorts

Two-to-three-minute reads on a single clinical question.

KOL video bites

Expert perspectives in three-to-five-minute clips.

Journal digests

Landmark and recent trials summarised with key numbers.

Guideline snapshots

What changed, and what it means in clinic.

Quizzes & case challenges

Test and reinforce, with instant explanations.

Patient education

Leaflets and videos doctors and pharmacists can share.

Interactive tools

Lung-sound and ECG trainers, calculators and checklists.

Safety alerts

Interaction, storage and pharmacovigilance reminders.

Already live

A growing library across specialties

MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.

The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.

NeurologyCardio-metabolicRespiratoryOrthopaedicsOncologyWomen's healthCritical careDermatologyDentalOphthalmology

Browse the content library

Fewer, shorter and better-targeted messages, shared by everyone around the patient, do more than any single detailing call.The idea behind the MedShorts network

Bring your brand science to the whole care chain

Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.

Talk to our team